ofer sharon
@oferorama
ID: 24572290
15-03-2009 19:36:28
442 Tweet
27 Followers
37 Following
#ISLB24 abstract submission open. Come one, come all. Denver Co, Nov 23-25. International Society of Liquid Biopsy Christian Rolfo
#WCLC2024 Getting ready for our ES04 session tomorrow on Challenges in Immunotherapy. New are polling questions. Here is my first, on Hyperprogressive Disease, as per Marina Garassino Do you “believe”?
יונתן שימריז. בהיעדר הנהגה, קמו מנהיגים. yonatan shamriz | יונתן שמריז
#ISLB2024 Annual Congress. Can't wait to hear Mary's insights at Multidisciplinary Stakeholder Workshop. Check out panelists & questions posed to Panel #1 on clin applications. (Panel 2 -translational sci) International Society of Liquid Biopsy Christian Rolfo Umberto Malapelle ELO M JOSE SERRANO Lab (LB&Cancer Interception group)
Meet Ofer Sharon (ofer sharon) at #ISLB24! Ofer Sharon, MD is the CEO of OncoHost, a precision oncology company developing a liquid biopsy test combining AI, system biology, and bioinformatics. Ofer is a physician and serial biotech entrepreneur. Register Now at
Continuing with showcase presentation at #ISLB24 by OncoHost on plasma proteomics in Immunotherapy presenting their pipeline and data. International Society of Liquid Biopsy David Gandara
We have previously described a novel plasma proteomic predictor for immunotherapy of NSCLC. doi.org/10.1200/PO.23.… At AACR 2025 we present the biological rationale and function of these proteins. Potential broad therapeutic implications doi.org/10.1158/1538-7… International Society of Liquid Biopsy